Abstract
Tactical athletes (TAs), including military service members, firefighters, and law-enforcement officers, perform physically demanding occupations in which sudden incapacitation carries substantial individual and public safety consequences. Across TA disciplines, traditional atherosclerotic cardiovascular disease (ASCVD) risk factors (e.g. hypertension, obesity, insulin resistance, sleep disturbance) are highly prevalent and commonly undertreated. Additionally, there are unique occupational stressors (e.g. heat exposure, inhalational hazards, performance enhancing drugs) which may contribute to ASCVD and cardiovascular (CV) mortality. Despite generally high baseline fitness, these populations experience a disproportionate burden of ASCVD, and sudden cardiac death (SCD) is the number one cause of duty-related mortality. Moreover, TAs represent a population in whom baseline fitness can obscure substantial cardiometabolic risk, and because sudden incapacitation has consequences beyond the individual, prevention should shift from symptom-triggered evaluation to systematic risk-factor detection, aggressive risk-factor control, and selective use of non-invasive atherosclerosis imaging. This state-of-the-art review summarizes current evidence on the prevalence of ASCVD risk factors and coronary artery disease (CAD) in TAs, CV screening practices, and management considerations for CAD among TAs.
Keywords: Prevention, Tactical athlete, Coronary artery disease, Cardiovascular risk factors
1. Introduction
Tactical athletes (TA), including military service members, firefighters, and law enforcement officers (LEOs), are a large, heterogeneous workforce engaged in physically demanding and high-stakes occupations in which sudden medical incapacitation can have substantial implications for both the individual and the public they serve [1]. While TA populations generally have higher baseline fitness compared to the civilian workforce, they experience a disproportionate burden of cardiovascular (CV) morbidity and mortality driven by traditional atherosclerotic cardiovascular disease risk (ASCVD) factors as well as unique occupational and environmental stressors [2]. Sudden cardiac death (SCD), largely due to coronary artery disease (CAD), is the leading medical cause of duty-related mortality across TA disciplines. Effective CV prevention in TAs requires approaches extending beyond general population-based models that incorporate more comprehensive CV risk assessment, earlier detection of subclinical disease, and management strategies tailored to the unique physiologic and operational demands of tactical occupations. Accordingly, this state-of-the-art review summarizes the prevalence of ASCVD risk factors and CAD in TAs, the incidence and etiology of SCD in TAs, current CV screening practices, and strategies for prevention and management of CAD across TA occupations.
2. Prevalence of traditional CV risk factors in tactical athletes
Despite occupational fitness requirements, traditional CV risk factors are common in TA populations and often worsen over the course of a career (Central Illustration). In the next sections, we review the prevalence of traditional CV risk factors in TAs per the American Heart Association (AHA)- Life’s Essential 8 framework [3].
Central Illustration.
Overview of traditional and unique risk factors for development of coronary artery disease and sudden cardiac death risk in Tactical athletes. Definition of Abbreviations: CRF= cardiorespiratory fitness, CV= cardiovascular, SCD= sudden cardiac death.
2.1. Hypertension
Large occupational cohort studies have demonstrated that approximately 60-75% of firefighters and emergency responders meet criteria for elevated blood pressure or hypertension (HTN), with the prevalence increasing significantly with age and years of service and exceeding that observed in age-matched civilian populations [[4], [5], [6]]. Additionally, fewer than one in five hypertensive individuals have adequate blood pressure control, highlighting a substantial treatment gap in a population at elevated risk for duty-related cardiac events [6]. The prevalence of elevated blood pressure has been estimated as 70% in U.S. active duty military members, and HTN has been estimated between 26-47% in military cohorts, with important occupational implications related to deployability and operational readiness [2,[7], [8], [9], [10]]. There are limited studies assessing the prevalence of elevated blood pressure and HTN in LEOs, but available estimates suggest a higher prevalence compared to the general population, with the risk of diagnosed HTN increasing significantly over the span of a career [[11], [12], [13], [14], [15]]. A large cross-sectional study conducted in British LEOs demonstrated significant associations between HTN and several modifiable lifestyle factors including waist circumference (odds ratio 0.52, 95% CI 0.50-0.54), sleep duration (odds ratio 0.94, 95% CI 0.90-0.98), and physical activity (odds ratio 0.88, 95% CI 0.85-0.90), suggesting that HTN in this TA discipline is closely linked to modifiable lifestyle factors [16]. Studies have also demonstrated that extended shifts, overnight duty, and increased job demands are independently associated with higher systolic and diastolic blood pressure, which may explain HTN risks among firefighters and other emergency responders [5,17].
2.2. Obesity
Cross-sectional studies in U.S. LEO cohorts have estimated that 34-60% of individuals in this TA discipline meet criteria for obesity [[18], [19], [20], [21]]. Similar patterns have been observed in U.S. firefighter cohorts, where obesity prevalence has been estimated as between 30-40% and may be closely related to traditional CV risk factors and reduced cardiorespiratory fitness, both of which are associated with increased risk of duty-related cardiac events [[22], [23], [24], [25]]. Among military personnel, population-level data have demonstrated that approximately 67% of active-duty service members meet criteria for being overweight (body mass index (BMI) ≥25 kg/m2) and 18% meet criteria for obesity (BMI ≥30 kg/m2), with a low prevalence of ideal BMI even at younger ages [2,26]. It is important to highlight the limitations of BMI in TA populations who may have higher amounts of lean muscle mass, so other measurements of body fat (bioelectrical impedance, dual energy X-ray absorptiometry, skinfold calipers, hydrostatic weight) or central adiposity (waist circumference, waist to hip, waist to height ratio) likely have more utility in this cohort. Importantly, meta-analyses across military and LEO populations have shown that metabolic syndrome, driven in large part by central adiposity, is common and confers a substantially elevated risk of cardiovascular disease (CVD) [26]. The higher prevalence of obesity in these groups may be related to occupation-related factors including high-stress environments and irregular shift work [22].
2.3. Insulin resistance and diabetes mellitus
Survey studies in U.S. LEO cohorts have reported a prevalence of diabetes of around 6% [15]. While similar prevalence data for U.S. firefighters are limited, longitudinal data from a cohort of 656 firefighters (90% male) have shown that while baseline rates of elevated blood glucose were initially low at approximately 1%, they were found to triple to 3% over a five-year period as the cohort aged [27]. The significance of these metabolic changes is highlighted by their link to subclinical atherosclerosis. For example, fasting insulin levels and insulin resistance have been independently associated with CAC burden, carotid intima–media thickness, and ECG abnormalities in firefighters, even among asymptomatic individuals [28]. Similar trends have been observed in military populations, where approximately 2-3% of active-duty service members carry a diagnosis of diabetes, often developing the condition in mid-career despite sustained fitness requirements [2,29]. Importantly, dietary patterns, occupational stress, sleep disruption, shift work, and reduced cardiorespiratory fitness may be associated with insulin resistance and accelerate CAD risk in TAs [[30], [31], [32]].
2.4. Sleep disturbance
Across LEOs, military, and firefighter populations, shift work, extended duty hours, and overnight duties have been consistently associated with insufficient sleep duration, poor sleep quality, and circadian misalignment [33,34]. In a large study assessing sleep of LEOs in North America, 40.4% screened positive for at least one sleep disorder [19]. LEOs who screened positive for obstructive sleep apnea or any sleep disorder in this study had an increased prevalence of CVD [19]. In firefighter populations, sleep disturbance is equally prevalent. Studies have shown that 37.2% of firefighters screened positive for any sleep disorder, with 28.4% screening positive for obstructive sleep apnea and 6% for insomnia [35]. Prospective data utilizing actigraphy in LEOs have further demonstrated that objective measures of poor sleep quality, including prolonged sleep onset latency, reduced sleep efficiency, and frequent nocturnal awakenings, are independently associated with an 89% higher risk of incident HTN, even after adjustment for shift work, BMI, and other lifestyle factors [36]. Similar associations have been observed in firefighter cohorts, where both short sleep duration and poor sleep quality have been linked to a higher prevalence of obesity, HTN, and excess adiposity [37]. Among military service members, sleep disturbances have been similarly shown to be common, with nearly 72% of some cohorts reporting poor sleep quality, particularly in the setting of deployment and post-traumatic stress, and are associated with higher rates of HTN, smoking, obesity, and other CV risk factors [34].
2.5. Physical inactivity or impaired cardiorespiratory fitness
Minimum physical activity standards differ between TA disciplines and jurisdictions, with some requiring annual fitness tests to be considered fit for duty and others having no clear standards. Despite mandated physical training, measurable proportions of U.S. military service members fail required fitness assessments (Table 1). For example, in a cohort of 605 female active-duty U.S. Army service members, 8% failed required physical fitness testing, with substantially higher failure rates observed in reserve components [38]. National fitness standards for LEOs in the US are unclear, and requirements are largely determined by local jurisdictions. While large-scale cross-sectional data of activity patterns in US LEOs are lacking, small studies using accelerometry have demonstrated that LEOs are more active on their non-working days and some LEO duties may include significant sedentary time [39]. For U.S. firefighters, the National Fire Protection Agency (NFPA) 1582 recommendations provide age and sex-specific cardiorespiratory fitness recommendations to be deemed “fit for duty” and recommend restrictions if less than the 35th percentile for expected metabolic equivalents (METs) or peak oxygen uptake (VO2, Table 2). A systematic review and meta-analysis among firefighters demonstrated strong inverse associations between cardiorespiratory fitness (most often derived by stress testing) and multiple CV risk factors, including HTN, obesity, dyslipidemia, and diabetes [40]. In a survey study of 527 US Firefighters, only 20% of firefighters reported meeting physical activity standards of ≥150 mins of moderate intensity activity per week [41]. Additionally, a small accelerometry study of 29 U.S. firefighters demonstrated that only 59% met physical activity guideline recommendations while on-duty and 31% during off-duty days [42]. These findings are particularly sobering given that in a 2024 National Health Interview Study, 47.2% of US adults met federal aerobic physical activity guidelines, highlighting an interesting paradox within TA occupations [43]. While duty-related tasks require intermittent bouts of extreme physical exertion, many TAs may not engage in sufficient overall physical activity, both on and off duty, to maintain cardiorespiratory fitness, especially as they age or transition into more sedentary roles [22].
Table 1.
Physical fitness testing components by service branch in the US department of war.
| US Military Branch | U.S. Air Force / U.S. Space Force | U.S. Army | U.S. Navy |
|---|---|---|---|
| Test | Physical Fitness Assessment (PFA) | Army Fitness Test (AFT) | Physical Readiness Test (PRT) |
| Frequency | Biannually | Biannually | Biannually |
| Minimum Fitness Standard | |||
| Aerobic/Cardiorespiratory Fitness | 2-mile run* OR 20-meter High Aerobic Multi-Shuttle Run (HAMR) | 2-mile run* | 1.5 mile run* OR 500-yard swim OR 2,000-meter row OR 12-minute stationary bicycle |
| Muscular Fitness | Push-ups (1-minute) OR hand release push-ups (2-minutes) AND Sit-ups (1-minute), cross-leg reverse crunches (2-minutes), OR forearm plank | Maximum deadlift (3 repetitions), hand release push-ups, sprint-drag-carry (50-meter shuttles using two 40-lb kettlebells and 90-lb sled), AND forearm plank | Push-ups (2-minutes) AND forearm plank |
Maximum run times vary by branch, sex, and age. For example, the maximum 2-mile run time for an Air Force male younger than 25 years is 19:45, for an Army male age 17-21 the maximum 2-mile run time is 19:57, and for a Navy male age 17-19 the maximum 1.5-mile run time is 12:45.
The Air Force PFA standards can be referenced at: https://www.afpc.af.mil/Portals/70/documents/FITNESS/PFRA%20Scoring%20Charts.pdf
The Army AFT standards can be referenced at:
https://www.army.mil/e2/downloads/rv7/aft/AFT_Scoring_Scales_250601.pdf
The Navy PRT standards can be referenced at:
Table 2.
NFPA 1582 minimum cardiorespiratory fitness recommendations to work without restrictions as a US firefighter.
![]() |
Definition of Abbreviations: MET= metabolic equivalent of task, Peak VO2= maximal oxygen uptake. Peak VO2 was calculated as 1 MET= 3.5 ml/kg/min. The data in this Table was derived from updates on cardiorespiratory fitness for the NFPA evaluations. The values above are the 35th percentile of what is expected from general population normative values, for which work restrictions are recommended.
2.6. Dyslipidemia
Dyslipidemia is highly prevalent across TA populations and represents an important modifiable contributor to ASCVD risk. Among U.S. military personnel, dyslipidemia is common even in relatively young and physically active cohorts. In a study of more than 3 million active-duty U.S. service members, the prevalence of hyperlipidemia was 11% using electronic health record diagnostic codes [44]. However, a more recent systematic review assessing the global prevalence of cardiometabolic risk factors among military service members reported 32% (95% CI 27-36%) with high low density lipoprotein cholesterol (LDL-C) and 24% (95% CI 16-31%) with high triglycerides [9]. Dyslipidemia is also prevalent among LEOs with cohort studies indicating that 54-62% of officers had LDL-C of 100 mg/dL or greater, 24-29% had low high density lipoprotein cholesterol (HDL-C), and 29-32% had elevated triglycerides (≥ 150 mg/dL) [45]. In firefighters, studies have shown that approximately 33-40% of personnel have dyslipidemia, often associated with higher body fat percentages and lower aerobic capacity [22,46]. Given that some TAs have higher than expected rates of obesity, insulin resistance, high triglycerides and central adiposity, LDL-C alone may also underestimate atherogenic particle burden so the addition apolipoprotein B (ApoB) may improve risk assessment [47,48]. The prevalence of dyslipidemia in TAs may be driven by poor dietary habits necessitated by unpredictable occupational demands, the high-stress nature of the work which affects lipid metabolism, or the common finding of central adiposity across these disciplines [22,45]. We are unaware of large-scale studies assessing Lp(a) levels in TAs, although given genetic determinants of Lp(a) levels, TA habits or lifestyle factors are not likely to significantly affect baseline values.
2.7. Tobacco and nicotine exposure
Tobacco use is highly prevalent among TA populations and represents another modifiable contributor to CV risk. In a study of the U.S. military service members using a 2018 medical questionnaire, 37.8% of service members reported use of tobacco or nicotine products [49]. Among first responders, patterns appeared to differ by product type. In a 2011 study of 677 male firefighters, cigarette smoking prevalence ranged from 13-17%, while smokeless tobacco use was disproportionately high at 16-18%, exceeding rates in the general population [50]. Similarly, in a 2011 study of 464 LEOs, current smoking prevalence was reported as 16.7% [51]. In a more recent study assessing tobacco use from 1992-2019, the prevalence of smoking decreased over time in all groups (firefighters, LEOs, non-first responders), although smokeless tobacco use did not significantly change among firefighters and LEOs and decreased in non-first responder occupations [52]. Overall, tobacco exposure remains high in TA disciplines, likely driven in part by occupational stressors, cultural norms, and policy environments. Given the well-established associations between nicotine use and adverse CV outcomes, targeted tobacco cessation strategies should be a central component of ASCVD prevention in TAs [53,54].
2.8. Diet
Dietary patterns across TA populations often deviate from CV guidelines, characterized by a high intake of processed foods, sugar-sweetened beverages, and saturated fats. In LEO cohorts, including the Airwave Health Monitoring Study of British police employees, suboptimal dietary patterns are common and are associated with increased cardiometabolic risk [30]. Similar patterns have been observed in firefighter populations, where studies have shown poor overall diet quality characterized by frequent consumption of fast food, refined carbohydrates, and processed foods [55]. Among military service members, diet quality is frequently suboptimal despite access to dining facilities, with studies demonstrating low adherence to dietary guidelines and overall Healthy Eating Index scores in the “needs improvement” range [56]. The prevalence of poor nutrition in TAs is likely driven by a combination of biological and logistical mechanisms. Unpredictable occupational demands and long shift work frequently lead to unstructured eating patterns, where TAs may rely on highly processed, shelf-stable foods due to limited access to healthy options during night shifts or emergency responses [30]. Further, the high-stress environment of tactical occupations may trigger cortisol-mediated stress eating, which has been shown to shift preferences toward calorie-dense, palatable foods as a coping mechanism [16]. These occupational constraints are compounded by unreliable meal times and a workplace culture that often prioritizes meals with greater fat and refined carbohydrate content [22].
3. Prevalence of unique occupational risk factors in tactical athletes
In addition to traditional CV risk factors, TAs are exposed to distinct occupation-specific physiologic and environmental stressors that may contribute to the development or progression of ASCVD, provoke acute CV events, and increase the risk of SCD (Central Illustration). These exposures, which often accumulate over years of service, are incompletely assessed by conventional risk calculators and may, in part, explain the disproportionate burden of CVD observed in TAs.
3.1. Performance enhancing drugs
The use of performance enhancing drugs (PEDs), including anabolic-androgenic steroids (AAS), stimulants, and supplements, have been reported across TA populations, particularly among individuals seeking to maintain strength, endurance, or body composition standards. AAS use, leading to supraphysiologic testosterone levels, has been associated with adverse CV remodeling, including increased left ventricular mass, impaired systolic and diastolic function, dyslipidemia, endothelial dysfunction, and increased coronary plaque burden, even among young and otherwise physically active individuals [[57], [58], [59], [60], [61]]. When compared with AAS non-users, long-term AAS users had significantly lower left ventricular ejection fraction and accelerated coronary atherosclerosis, suggesting a link between AAS use and elevated CV risk [57,61]. Additionally, observational studies in athletic cohorts with traditionally high PED use, such as bodybuilding, have demonstrated increased risks of SCD [62]. Stimulant agents used for performance enhancement have been associated with increased sympathetic activation, HTN, and arrhythmias, and may further increase CV risk by allowing supraphysiologic exertion beyond normal limits [63]. There is limited data on the prevalence of stimulant use for performance in TAs or on associations with SCD risk among individuals with CAD. However, historical military data provide some insight. For example, a survey of U.S. Air Force fighter pilots during Operation Desert Storm found that 57% had used stimulants to manage fatigue, with 17% utilizing them routinely [64].
3.2. Smoke inhalation and particulate matter exposure
Occupational smoke exposure, particularly in firefighters and disaster responders, also may play a significant role in the CV risk profile of TAs. In addition to physiologic strain, inhaled combustion products and fine particulate matter may contribute to endothelial dysfunction, thrombogenicity, and myocardial oxygen supply-demand mismatch, mechanisms that plausibly increase risk both during and shortly after smoke-intensive operations [65]. Beyond firefighting, large-scale exposure events demonstrate similar signals. For example, in World Trade Center responders, studies demonstrate associations between higher exposure intensity and increased long-term CVD risk, suggesting that sustained inhalational and disaster exposures, often coupled with psychological stress, may have long-term CV consequences [[66], [67], [68]].
3.3. Burn pits and deployment-related airborne hazards
Open burn pits generate complex airborne exposures including particulate matter, volatile organic compounds, and combustion byproducts that have been associated with adverse CV outcomes. In a large Veterans Health Administration cohort study leveraging deployment duration to bases with burn pits, longer exposure was associated with modestly increased odds of HTN (odds ratio 1.02, 95% CI 1.01-1.03) [69]. These findings support a possible link between chronic particulate exposure and systemic inflammation with vascular dysfunction and longitudinal increases in blood pressure, though it should be noted that effect sizes were modest and outcome ascertainment varied by system and follow-up [69]. Additional studies of patients with prior deployments to bases that used open burning of unsegregated waste similarly demonstrate an association with increased risk of HTN [70]. These findings emphasize that burn pit exposure is heterogenous and detailed characterization of exposure and further research are important.
3.4. Thermal injury and heat illness
Heat illness may impose significant myocardial and circulatory strain through cutaneous vasodilation and compensatory tachycardia, increased sweat secretion and hemodilution, activation of inflammatory cascades, and direct thermal tissue injury and organ hypoperfusion [71]. Previous literature suggests heat-related illness may have long-term CV consequences. A study of US Army personnel (1971-2000) compared individuals hospitalized for severe heat illness (n=3,971) with individuals hospitalized for appendicitis (n=17,233), and found that prior heat illness was associated with a higher risk of cardiovascular death (risk ratio=1.7) and ischemic heart disease (risk ratio=2.2) [72]. Additionally, in a large prospective study in China (n=9,658,745) of individuals free of CVD with 6-year follow-up, heat-related illness was associated with the development of CVD (hazard ratio 2.5, 95% CI 2.3-2.8) [73]. A systematic review of long-term sequelae also demonstrated an association between a history of heat stroke with increased subsequent CVD risk, including ischemic heart disease, heart failure, and atrial fibrillation [74].
4. Prevalence of subclinical coronary atherosclerosis in tactical athletes
A growing body of evidence suggests that some TAs may exhibit a higher-than-expected prevalence of subclinical atherosclerosis, as measured by coronary artery calcium (CAC) scores. In the Prospective Army Coronary Calcium project, which evaluated 2,000 asymptomatic active-duty military personnel (mean age 43 years), CAC was identified in 22.4% of men and 7.9% of women [75]. Notably, the presence of CAC in these young, asymptomatic men was associated with an 11.8-fold increased risk for incident coronary heart disease, independent of Framingham risk scores [75]. Among firefighters, previous studies have demonstrated that approximately 87-91% of firefighters may have higher than expected CAC scores compared to expected values from the general population, and one study demonstrated that CAC may be identified in male firefighters as young as 34 years old [76,77]. Interestingly, a large-scale study of New York City LEOs found CAC prevalence to be similar to the general population [78]. These studies suggest that there may be higher than expected CAC scores in certain TA disciplines. However, we are unaware of large prospective studies assessing the effect of CAC scores on CV morbidity/mortality or occupational risk in TAs, so future studies could inform evidence-based screening protocols.
5. Sudden cardiac death in tactical athletes
5.1. Military
SCD represents a leading cause of nontraumatic mortality among active-duty military personnel. Large epidemiologic analyses of U.S. service members have demonstrated that SCD incidence in military cohorts exceeds that observed in age-matched athletes, particularly during periods of strenuous physical exertion, training, or operational stress [[79], [80], [81], [82]]. Specifically, the incidence of SCD in young military populations has been estimated as 5.1-10.2 per 100,000 recruit-years (age range 17-24 years old) which is higher than the 1.57 per 100,000 athlete-years incidence observed in National Collegiate Athletic Association athletes (age range 17-26 years old) [79,83]. In the military, the underlying causes of SCD shift dramatically as service members age. In service members under the age of 35, the majority of cases were attributed to autopsy-negative sudden unexplained death (35%) or coronary artery anomalies (19%), with CAD accounting for only 9% of deaths [80]. However, in service members aged 35 and older, the incidence of SCD more than triples to 35.4 per 100,000 person-years, and 73% of these fatal events were caused by obstructive CAD [80]. Importantly, many fatal events occur during or immediately following intense physical activity, suggesting that acute exertional and adrenergic stress may act as triggers in individuals with subclinical coronary disease [81,84,85]. Overall, these findings emphasize that traditional fitness metrics and occupational readiness requirements may fail to fully mitigate SCD risk in military populations when subclinical atherosclerosis is present.
5.2. Firefighters
Among firefighters, SCD is the leading cause of duty-related death, accounting for approximately 40-50% of line-of-duty fatalities in the US [[86], [87], [88], [89], [90]]. The incidence of SCD in firefighters has been estimated to range between 3.8 per 100,000 person years (age range 18-24 years old) to 45.2 per 100,000 person years (age range 55-64 years old) [90]. The risk of SCD was strongly associated with tactical duties, with fire suppression (12-136x higher risk), alarm response (3-14x higher risk), and physical training (3-7x higher risk) conferring disproportionately high relative risk compared to nonemergency station duties [88]. Postmortem studies provide compelling evidence that CAD is the most common pathologic substrate underlying these deaths. Large autopsy series demonstrate that 60% of firefighters with SCD exhibit significant coronary artery stenosis (defined as ≥75% stenosis) [86,[91], [92], [93]]. Notably, in a cohort of 276 duty-related SCDs, both CAD burden and increased cardiac mass were independently associated with substantially increased risk [92].
5.3. Law enforcement
LEOs similarly experience elevated rates of duty-related SCD, with CV events representing a leading cause of on-duty mortality. Epidemiologic studies from US LEOs have demonstrated that, compared with routine or non-emergency activities, the relative risk of SCD was increased approximately 34-69x during physical restraints or altercations, 32-35x during pursuits, 20-23-fold during physical training, and 6-9x during medical or rescue operations [94]. These events are thought to be precipitated by acute surges in sympathetic activation superimposed on underlying CAD. Although systematic postmortem characterization of line-of-duty deaths in LEOs is limited, we hypothesize these CV deaths are likely related to subclinical CAD consistent with patterns observed in military and firefighter populations [95]. Similar to these groups, traditional CV risk factors are highly prevalent among LEOs and when combined with occupational factors, likely contribute to subclinical atherosclerosis [14].
6. Current cardiovascular screening protocols for tactical athletes
Existing CV screening protocols for TAs vary substantially, reflecting differences in mission requirements, operational risk tolerance, and the degree of standardization across military, fire service, and LEO organizations (Table 3).
Table 3.
National cardiovascular screening recommendations for united states fire service, military (Non-specialized service members), and Law Enforcement Officers.
![]() |
Definition of Abbreviations: PHA= Periodic Health Assessment, POST= Peace Officer Standards and Training, ACOEM= American College of Occupational and Environmental Medicine, BP= blood pressure, CAC= coronary artery calcium, CBC= complete blood count, CRP= C-reactive protein, CTA= computed tomography angiography, CV=cardiovascular, ECG= electrocardiogram, HDL= high-density lipoprotein, HR= heart rate, LDL= low-density lipoprotein, NFPA= National Fire Protection Association, TG= triglycerides
*Includes height, weight, circumferential measurements, skinfold testing, hydrostatic weighing or Bod-pod, bioimpedance analysis
**ACC/AHA Pooled Cohort Equation 10-year risk or Framingham Heart Study 2-year risk prediction. There is also a recommendation that “Asymptomatic firefighters younger than 40 years of age known to be at high risk for ASCVD shall be assessed for coronary artery disease”
∴Performed through branch-specific physical fitness testing (PFA, AFT, PRT).
^Not included in the majority of published standards for law enforcement officers. May be performed in some jurisdictions.
^^There is broad guidance for military PHA assessments to follow US Preventive Services Force Grade A recommendations which are variably followed in clinical practice, so it is possible that military members could have periodic lipid measurements or other testing but there is currently no set CV screening protocol.
°Elements recommended in California POST evaluations. Framingham 2-year risk estimates are calculated to guide decision on stress testing and CAC score.
6.1. Military
In the U.S. military, CV screening occurs upon entry, or accession to the military, and annual periodic health assessments (PHAs, Table 3). At accession, a comprehensive medical history and physical exam is performed without any other mandated CV screening, unless competing for specialized units [96]. For annual PHAs, a standardized virtual questionnaire that utilizes self-reported data to identify potential health risks is completed by active-duty service members. Further evaluation including physical exams and CV diagnostic testing are not routinely performed unless there are concerns based on the PHA questionnaire. Routine preventive screening during PHAs is supposed to broadly follow grade A U.S. Preventive Services Task Force (USPSTF) recommendations, but these are variably implemented in everyday practice (notably screening for diabetes has previously been designated a grade B recommendation by the USPSTF, and lipid screening a grade A recommendation for men ≥35 years and women ≥45 years old) [97]. Beyond these recommendations, there are no universal structured mandatory CV screening evaluations, including periodic laboratory assessments (e.g., lipid panels, metabolic panels, and hemoglobin A1c), resting electrocardiograms (ECGs), stress testing, or anatomic coronary imaging (Table 3). Any CV testing must be ordered by the clinician based on their judgment, the patient’s reported symptoms, or specific occupational requirements (e.g., aviation or special operations). Consequently, subclinical ASCVD risk factors and CAD may be underrecognized with this screening approach.
6.2. Fire service
In contrast to the military’s broad readiness-focused model, there are national recommendations from the National Fire Protection Agency (NFPA) for occupational medical testing among firefighters which provide yearly recommendations for CV screening. The most recent iteration of NFPA 1582 occupational medical standards were published in the NFPA 1580: Standard for Emergency Responder Occupational Health and Wellness document [98]. However, implementation and frequency of NFPA 1582 testing are determined at the jurisdiction level and often subject to firefighter union negotiation. CV risk stratification from the NFPA 1582 recommendations include assessment of body composition (height, weight), resting vital signs (heart rate, blood pressure), a comprehensive medical history and physical exam, exposure history (e.g. smoke exposure), CV risk score (2-year Framingham risk tables or 10-year ACC/AHA ASCVD risk score calculator), blood work (inclusive of traditional lipid panel, blood glucose, renal function), resting ECG (recommended in initial evaluation, and annually after age 40), an exercise test (to assess exercise capacity), and an ECG stress test with imaging if 10-20% 10-year ASCVD risk (Table 3).
6.3. Law enforcement
For LEOs, CV screening is comparatively decentralized, with no known single national standard analogous to NFPA 1582 for firefighters. As a result, current CV screening protocols are best characterized as a combination of occupational medicine guidance and jurisdiction-specific medical standards (Table 3). The California POST (Peace Officer Standards and Training) Medical Screening Manual serves as a prominent example of a structured approach to initial evaluation for LEOs [99]. In California, the evaluation of patrol officer candidates requires a comprehensive history, physical examination, and a 12-lead ECG for all candidates. The physical exam is highly specific, requiring auscultation for carotid and abdominal bruits in addition to the assessment of jugular venous pressure. Lipid panels are required for male candidates age 35 or older and female candidates age 45 or older to calculate a 2-year Framingham cardiac event risk score. While a treadmill ECG stress test is not universally required, it is indicated for any candidate believed to be at an increased risk of sudden incapacitation based on their medical history or identified risk factors. Despite the prescriptive nature of the California POST, it should be emphasized that significant variation exists across the country. Many states do not mandate such specific statewide minimum medical standards and often leave periodic evaluation to the discretion of local agencies.
7. Future considerations for cardiovascular screening in tactical athletes
Current CV screening recommendations in TA disciplines are heterogeneous (Table 3) and often do not follow contemporary CV prevention practices in the general population. CV screening may be virtually non-existent for military service members pending evaluations of their yearly virtual health questionnaire, and there are no national standards for LEOs so there also may not be adequate CV screening. Firefighters have the most robust national recommendations for CV screening, but the current NFPA 1582 recommendations have significant limitations in the identification of CV risk factors and CAD. For example, firefighters are required to have a resting ECG at baseline and then annually after the age of 40 years old. While a resting ECG may identify inherited conditions associated with SCD among young TAs, its sensitivity for identifying CAD is significantly limited, and its addition to traditional risk models has not been shown to improve the classification of asymptomatic individuals [100]. Additionally, multiple studies in the general population and among TAs demonstrate a limited sensitivity of an ECG stress test, which is currently recommended for firefighters with intermediate or greater risk on CV risk scores [101]. Most stress protocols do not use customized testing to recreate tactical duties which may be able to increase diagnostic yield, [102] and there is no recommended anatomic imaging evaluation to identify subclinical CAD or CAD not associated with ischemia (e.g. CAC scores or coronary computed tomography angiography) even though multiple studies have demonstrated that firefighters have higher than expected CAC scores [76,77]. Finally, the recommended laboratory workup in firefighters for risk stratification does not include various biomarkers associated with CVD risk like Lp(a) [103]. Given that SCD is a leading cause of duty-related mortality in TA disciplines and is most often related to CAD, future protocols should consider adapting practice to more contemporary CV screening recommendations and future studies are needed to validate the efficacy of these protocols.
An overview of a recommended framework for CV screening in TAs is presented in Table 4. Notably, an effective medical screening program needs to balance medical safety with operational and logistical feasibility. The proposed framework represents a best-case scenario, but operational considerations are important, so in low-risk individuals, increasing the interval between some screening recommendations may be reasonable as denoted in Table 4.
Table 4.
Recommended framework for cardiovascular screening in asymptomatic tactical athlete disciplines*.
| CV screening Modality | Screening Interval | Comments/Evidence Base |
|---|---|---|
| Medical History and Physical Exam | ||
| Comprehensive Medical History | Annually | Should be inclusive traditional CV risk factors/risk enhancers and unique TA occupational risk factors: - CV risk factors/enhancers per 2026 multisociety dyslipidemia guidelines[48] - Inhalational exposures, burn pit exposures, PED use, exertional heat illness history - Tobacco/nicotine screening, other substance use - Screening for sleep-related illness/sleep apnea |
| Vital Signs (Resting HR/BP) | Annually | There should be a low threshold for consideration of home or ambulatory blood pressure monitoring[4] |
| Physical Exam | Annually | |
| Body Composition⁎⁎ | Annually | Recommend measurement of body fat (e.g. bioelectrical impedance, dual energy X-ray absorptiometry, skinfold calipers, hydrostatic weight) and/or central adiposity (e.g. waist circumference, waist to hip, waist to height ratio) |
| CRF Fitness Assessment | Annually | TA discipline-specific physical fitness testing should be considered to determine CRF and fit-for-duty status |
| Blood work/Risk Score Assessment | ||
| Glucose/Hgb A1c | Upon entry, then every 1-3 years starting at age 35 | Per the 2026 American Diabetes Association Guidelines[119] |
| Lipid Panel | Upon entry, repeat every 5 years until age 39, then annual screening | Per the 2026 multisociety dyslipidemia guidelines[48]. Consider apolipoprotein B testing once LDL-C/non-HDL-C goals are achieved especially in those with cardiovascular-kidney-metabolic syndrome, obesity and/or high triglycerides. |
| Lipoprotein(a) | Single assessment upon entry | |
| CV Risk Score^ | Annually starting at age 30 | Would recommend PREVENT ASCVD risk score calculation starting at age 30 per 2026 multisociety dyslipidemia guidelines[48] |
| Other CV Testing | ||
| Resting ECG^^ | Single assessment upon entry, possible repeat pending TA age/discipline | Recommend at least a single resting ECG upon entry to screen for inherited conditions associated with SCA/D, similar to movements in competitive athletes[111]. |
| Subclinical Atherosclerosis Imaging (e.g. CAC score) | Periodic pending age/risk factor profile/occupational risk | Recommend considering CAC score for middle-age (e.g. ≥40 years old) TAs with borderline/intermediate predicted risk, multiple risk enhancers, prolonged occupational exposure, strong family history, elevated Lp(a), or uncertainty about intensity of lipid-lowering therapy. Individuals with CAC score=0 should consider repeat in 3-7 years. There is less value with repeat testing with CAC score >0. |
Definition of Abbreviations: CV= cardiovascular, TA= tactical athlete, PED= performance enhancing drug, HR= heart rate, BP= blood pressure, CRF= cardiorespiratory fitness, CRP= c-reactive protein, ASCVD= atherosclerotic cardiovascular disease, ECG= electrocardiogram, SCA/D= sudden cardiac arrest/death, CAC= coronary artery calcium, Lp(a)= lipoprotein (a)
*These recommendations are a proposed CV screening algorithm. However, operational/logistical concerns may not make this feasible for all TA disciplines. For example, if there are logistical concerns to yearly physical exams then can consider a reasonable interval for young TAs (e.g. every 3-5 years, with virtual assessment on other years) without symptoms or medical problems and increase frequency based on age, medical comorbidities, or tactical risk as appropriate. Additionally, if having labs drawn yearly per lipid or diabetes guidelines hinders operational commands, then a slightly increased interval (e.g. 3 years) could be considered in individuals with normal previous laboratory assessments or not deemed to be high-risk. All CV screening protocols must weigh medical safety concerns with logistical feasibility.
**If there are logistical constraints to assessing body composition, then could consider a BMI cutoff (e.g. BMI>25) where more specialized assessment of body composition is necessary
^CV risk score assessment should be calculated using most recent labs as feasible pending the reasonable lab interval determined by the TA discipline.
^^Has a poor predictive ability for CAD. Recommended for screening of inherited conditions associated with SCA/D among young TAs.
8. Management considerations of risk factors and CAD in TAs
Management of CVD in TAs extends beyond traditional risk reduction and symptom control, requiring careful integration of occupational demands, duty restrictions, medication side effects, and bleeding risk. In contrast to civilian populations, many TAs must safely perform high-risk tasks (e.g., load carriage, extreme exertion, heat exposure, combat or rescue operations) in environments where medical access may be delayed or unavailable. As a result, disease management strategies that are acceptable in the general population may carry disproportionate occupational risks in TAs and require individualized tactical decision-making.
8.1. Pharmacological therapies for treatment of CV risk factors and CAD in tactical athletes
Careful medication selection is paramount for the TA as standard therapies may conflict with the physiologic demands of the mission. Diuretic medications are often avoided or used with caution, as they may potentiate significant electrolyte abnormalities and impair thermoregulatory capacity during heat stress in environments often characterized by low resource availability and prolonged exertion [104]. Beta-blockers and nodal calcium channel blockers (CCBs) can impair maximal heart rate response and reduce exercise tolerance in highly trained and fit individuals, potentially compromising performance during sustained exertion [105]. This is especially true in high performance pilots where inability to augment cardiac output can lead to G-force induced loss of consciousness. Accordingly, pharmacologic agents that do not impair fitness or potentiate electrolyte abnormalities, such as dihydropyridine CCBs, are preferred for HTN management in TAs.
Regarding lipid-lowering therapy, statins remain the cornerstone for ASCVD risk reduction. TAs with high levels of physical exertion may have lower adherence rates than competitive athletes, who often report higher frequencies of statin-associated muscle symptoms (SAMS) compared to the general population [106]. For TAs who are statin-intolerant, alternative agents such as ezetimibe or bempedoic acid may offer favorable side-effect profiles [107]. While PCSK9 inhibitors provide profound LDL-C lowering with minimal muscle-related side effects, [108] their operational utility may be limited by logistical constraints. Injectable PCSK9 inhibitor agents generally require refrigeration, which may not be feasible during long-duration missions or in austere environments. However, inclisiran or emerging oral formulations of PCSK9 inhibitors may be options in these scenarios. These considerations necessitate careful medication selection and monitoring to maintain operational capability while preserving long-term CV benefit.
Given high rates of central adiposity and obesity, new pharmacological therapies for weight loss (glucagon-like peptide-1 receptor agonists) may play an important role in improving cardiometabolic health in the future. Similar to considerations for injectable PCSK9 inhibitors, emerging oral therapies and formulations that do not require refrigeration may be preferred for TAs who have prolonged travel or deployment.
Antithrombotic therapy also presents unique challenges in TAs due to the higher risk of traumatic injury, hemorrhage, and limited access to immediate medical care in some TA settings. Dual antiplatelet therapy (DAPT) is indicated following percutaneous coronary interventions (PCI) and substantially increases bleeding risk, particularly during the early post-PCI period. The increased bleeding risk may be incompatible with deployment or hazardous duties [109]. Long-term anticoagulant therapy also has significant TA occupational implications, as blunt trauma, blast exposure, or falls may result in catastrophic bleeding. Therefore, shared-decision making and thoughtful consideration of an individual’s tactical duties should be considered in every case where antithrombotic therapy may be indicated.
8.2. Asymptomatic coronary artery disease and revascularization
The approach to asymptomatic severe fixed CAD in TAs may differ from the management strategies often applied to the general population. In the ISCHEMIA trial, an initial conservative strategy of optimal medical therapy without revascularization was not associated with a higher risk of ischemic CV events or death from any cause compared to an invasive strategy in patients with stable CAD and moderate-to-severe ischemia [110]. However, the ISCHEMIA cohort did not specifically include a significant proportion of individuals engaged in the high-intensity, sustained physical exertion often demanded of TAs. In contrast, sports cardiology documents from both the American College of Cardiology/American Heart Association (ACC/AHA) and the European Society of Cardiology (ESC) recommend consideration of revascularization in asymptomatic athletes with severe fixed CAD in the presence of inducible ischemia [111,112]. This recommendation is driven by evidence that a proportion of SCD events in athletes may occur in the setting of fixed severe CAD thought to be due to ventricular arrhythmias in the setting of ischemia and catecholamine surges from exercise and competition [113,114]. In many TA disciplines, the risk of SCD of an individual may also put others in danger or have consequences for strategic missions, which may push clinicians to reduce any possibility of CV incapacitation. Finally, in certain high-risk occupations (e.g. military aviation), revascularization is not only a clinical consideration but a regulatory mandate for return-to-duty. For example, U.S. Air Force pilots diagnosed with obstructive CAD must undergo complete revascularization to be considered for a medical waiver. This requires successfully treating all lesions with flow limiting stenosis to minimize the risk of sudden in-flight incapacitation [115]. Ultimately, revascularization decisions in TAs must balance the clinical findings with occupational risk tolerance and the specific mission requirements.
9. Sex-specific CV screening and management considerations
The number of female TAs continues to grow as women increasingly enter the military and other disciplines historically composed primarily of men [116]. Female TAs differ from their male counterparts in that they may have sex-specific CV risk factors and risk enhancers, including early menopause, hypertensive disorders of pregnancy, history of preterm delivery, and gestational diabetes, all of which are increasingly recognized contributors to CAD risk [117]. Interestingly, however, the incidence of exercise-related SCD is significantly lower in female athletes compared with male athletes (ratio of 3:1–10:1) [118], and female SCD rates appear to be lower in certain TA populations (e.g. ratio of 4.8:1 in the U.S. military) [80]. Given the relatively limited available evidence regarding CV risk and outcomes in female TAs, there is a clear need for future research focused specifically on this population.
10. Conclusion
CVD is the primary driver of duty-related mortality in TAs, largely due to CAD. Despite high physical standards, TA populations have a disproportionate and often progressive burden of traditional CV risk factors that are compounded by unique occupational stressors. Current TA CV screening recommendations are extremely heterogeneous and are often not in line with contemporary standards in preventive cardiology. Additionally, management of CV risk factors and CAD requires an in-depth understanding of TA duties to individualize care for this specialized population. We present a proposed framework for CV screening for TAs to hopefully improve CV risk prediction and management. Future studies are needed to understand the most effective CV screening programs for early identification and treatment of CV risk factors and CAD in TAs.
Declaration of generative AI and AI-assisted technologies in the manuscript preparation process
During the preparation of this work the authors used ChatGPT (OpenAI, San Francisco, CA) to assist in the creation of icons used in the Central Illustration. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article.
Funding
Dr. Petek is the Medical Director of the Portland Fire and Police Bureau which pay a portion of his salary. Additionally, Dr. Petek’s Sports Cardiology Program receives compensation for pre-participation cardiovascular screening for the National Hockey League Scouting Combine, University of Portland, and Portland State University. Additionally, his Sports Cardiology Program has received funding from the Joel Cornette Foundation for the Outcomes Registry for Cardiac Conditions in Athletes study. Dr. Churchill receives funding from the National Institute of Health/National Heart, Lung, and Blood Institute (5K23HL159262-04) and receives compensation for his work with the Boston Bruins organization. Dr Moulson reports serving on advisory boards and/or receiving honoraria from Amgen, GSK, HLS Therapeutics, Novartis, NovoNordisk, and Sanofi. Dr. Shapiro has the following research grants (to his institution) - DCRI, Amgen, Boehringer Ingelheim, Cleerly, Novartis, Ionis, Lilly, Merck, New Amsterdam; serves on the following Scientific Advisory Boards: Amgen, Ionis, Esperion, Novartis, Regeneron, Lilly, Merck; and serves as a Consultant to: Novartis, Merck, Esperion, Astra Zeneca, Alnylam.
Trial registration
Not applicable
CRediT authorship contribution statement
John-Henry L. Dean: Conceptualization, Data curation, Writing – original draft, Writing – review & editing. Timothy W. Churchill: Conceptualization, Writing – review & editing. Samantha L. Weller: Visualization, Writing – review & editing. Nathaniel Moulson: Writing – review & editing. Caroline E. Murphy: Writing – review & editing. Eddie Davenport: Writing – review & editing. Charles A. German: Writing – review & editing. Michael D. Shapiro: Writing – review & editing. Bradley J. Petek: Conceptualization, Data curation, Writing – original draft, Writing – review & editing, Supervision.
Declaration of competing interest
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Bradley Petek reports a relationship with Portland Fire and Police Bureau that includes: employment. Bradley Petek reports a relationship with National Hockey League Scouting Combine, University of Portland, and Portland State University that includes: employment. Bradley Petek reports a relationship with Joel Cornette Foundation that includes: funding grants. Timothy Churchill reports a relationship with National Institute of Health that includes: funding grants. Timothy Churchill reports a relationship with Boston Bruins that includes: employment. Nathaniel Moulson reports a relationship with Amgen Inc that includes: consulting or advisory. Nathaniel Moulson reports a relationship with GSK that includes: consulting or advisory. Nathaniel Moulson reports a relationship with HLS Therapeutics Inc that includes: consulting or advisory. Nathaniel Moulson reports a relationship with Novartis that includes: consulting or advisory. Nathaniel Moulson reports a relationship with Novo Nordisk that includes: consulting or advisory. Nathaniel Moulson reports a relationship with Sanofi that includes: consulting or advisory. Michael Shapiro reports a relationship with Duke University Duke Clinical Research Institute that includes: funding grants. Michael Shapiro reports a relationship with Amgen Inc that includes: funding grants. Michael Shapiro reports a relationship with Boehringer Ingelheim Corp USA that includes: funding grants. Michael Shapiro reports a relationship with Cleerly Inc that includes: funding grants. Michael Shapiro reports a relationship with Novartis that includes: funding grants. Michael Shapiro reports a relationship with Ionis Pharmaceuticals Inc that includes: funding grants. Michael Shapiro reports a relationship with Eli Lilly and Company that includes: funding grants. Michael Shapiro reports a relationship with Merck that includes: funding grants. Michael Shapiro reports a relationship with New Amsterdam that includes: funding grants. Michael Shapiro reports a relationship with Amgen Inc that includes: board membership. Michael Shapiro reports a relationship with Ionis Pharmaceuticals Inc that includes: board membership. Michael Shapiro reports a relationship with Esperion Therapeutics Inc that includes: board membership. Michael Shapiro reports a relationship with Novartis that includes: board membership. Michael Shapiro reports a relationship with Regeneron Pharmaceuticals Inc that includes: board membership. Michael Shapiro reports a relationship with Eli Lilly and Company that includes: board membership. Michael Shapiro reports a relationship with Merck that includes: board membership. Michael Shapiro reports a relationship with Novartis that includes: consulting or advisory. Michael Shapiro reports a relationship with Merck that includes: consulting or advisory. Michael Shapiro reports a relationship with Esperion Therapeutics Inc that includes: consulting or advisory. Michael Shapiro reports a relationship with AstraZeneca that includes: consulting or advisory. Michael Shapiro reports a relationship with Alnylam Pharmaceuticals Inc that includes: consulting or advisory. Given his role on the American Journal of Preventive Cardiology Editorial Board, Bradley Petek had no involvement in the peer review of this article and had no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to another journal editor. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgements
None
Footnotes
The views expressed herein are those of the authors and do not reflect the official policy or position of Brooke Army Medical Center, the U.S. Army Medical Command, the US. Army office of the Surgeon General, the Department of the Air Force, the Department of the Army, the Department of War, or the U.S. Government.
References
- 1.Xu J., Haigney M.C., Levine B.D., Dineen E.H. The tactical athlete: definitions, cardiovascular assessment, and management, and “Fit for Duty” standards. Card Electrophysiol Clin. 2024;16(1):93–105. doi: 10.1016/j.ccep.2023.09.010. [DOI] [PubMed] [Google Scholar]
- 2.Shrestha A., Ho T.E., Vie L.L., et al. Comparison of cardiovascular health between US army and Civilians. J Am Heart Assoc. 2019;8(12) doi: 10.1161/JAHA.118.009056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Lloyd-Jones D.M., Allen N.B., Anderson C.A.M., et al. Life’s Essential 8: updating and enhancing the American heart association’s construct of cardiovascular health: a presidential advisory from the american heart association. Circulation. 2022;146(5):e18–e43. doi: 10.1161/CIR.0000000000001078. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Jones D.W., Ferdinand K.C., Taler S.J., et al. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American heart association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2025;86(18):1567–1678. doi: 10.1016/j.jacc.2025.05.007. [DOI] [PubMed] [Google Scholar]
- 5.Kales S.N., Tsismenakis A.J., Zhang C., Soteriades E.S. Blood pressure in firefighters, police officers, and other emergency responders. Am J Hypertens. 2009;22(1):11–20. doi: 10.1038/ajh.2008.296. [DOI] [PubMed] [Google Scholar]
- 6.Khaja S.U., Mathias K.C., Bode E.D., et al. Hypertension in the United States fire service. Int J Environ Res Public Health. 2021;18(10):5432. doi: 10.3390/ijerph18105432. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Hunter A., Holdsworth D.A., D’Arcy J., Bailey K., Casadei B. Hypertension in the military patient. J R Army Med Corps. 2015;161(3):200–205. doi: 10.1136/jramc-2015-000506. [DOI] [PubMed] [Google Scholar]
- 8.Rhee J., Beltran T., Choi Y.S. Elevated blood pressure among military emergency department patients. Mil Med. 2025;190(Supplement_2):704–709. doi: 10.1093/milmed/usaf314. [DOI] [PubMed] [Google Scholar]
- 9.Baygi F., Herttua K., Jensen O.C., et al. Global prevalence of cardiometabolic risk factors in the military population: a systematic review and meta-analysis. BMC Endocr Disord. 2020;20(1):8. doi: 10.1186/s12902-020-0489-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Stahlman S.L., Tantlinger L.M. Trends in hypertension and hypertensive disease among active component U.S. service members, 2018-2023. MSMR. 2025;32(8):22–23. [PMC free article] [PubMed] [Google Scholar]
- 11.Joseph P.N., Violanti J.M., Donahue R., et al. Endothelial function, a biomarker of subclinical cardiovascular disease, in urban police officers. J Occup Environ Med. 2010;52(10):1004–1008. doi: 10.1097/JOM.0b013e3181f4385c. [DOI] [PubMed] [Google Scholar]
- 12.Violanti J.M., Fekedulegn D., Burchfiel C.M., et al. Buffalo Cardio-Metabolic Occupational Police Stress (BCOPS) study: a seven- and twelve-year prospective analysis of occupational exposures and health outcomes among police officers. Int Arch Occup Environ Health. 2025;98(4-5):451–465. doi: 10.1007/s00420-025-02142-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Zimmerman F.H. Cardiovascular disease and risk factors in law enforcement personnel: a comprehensive review. Cardiol Rev. 2012;20(4):159–166. doi: 10.1097/CRD.0b013e318248d631. [DOI] [PubMed] [Google Scholar]
- 14.Franke W.D., Lefferts E.C., Lefferts W.K., et al. Law enforcement officers have an increased prevalence of subclinical cardiovascular disease that is not explained by traditional risk factors. J Occup Environ Med. 2024;66(7):590–596. doi: 10.1097/JOM.0000000000003119. [DOI] [PubMed] [Google Scholar]
- 15.Mumford E.A., Liu W., Taylor B.G., Ramey S. Profiles of US law enforcement officers’ diagnosed health conditions: results from a probability-based sample of officers. J Occup Environ Med. 2021;63(5):422–431. doi: 10.1097/JOM.0000000000002162. [DOI] [PubMed] [Google Scholar]
- 16.Aljuraiban G.S., Gibson R., Chan D.S.M., Elliott P., Chan Q., Griep LMO. Lifestyle score and risk of hypertension in the airwave health monitoring study of British police force employees. Int J Environ Res Public Health. 2023;20(5):4029. doi: 10.3390/ijerph20054029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Choi B., Schnall P., Dobson M. Twenty-four-hour work shifts, increased job demands, and elevated blood pressure in professional firefighters. Int Arch Occup Environ Health. 2016;89(7):1111–1125. doi: 10.1007/s00420-016-1151-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Gu J.K., Charles L.E., Burchfiel C.M., et al. Long work hours and adiposity among police officers in a US northeast city. J Occup Environ Med. 2012;54(11):1374–1381. doi: 10.1097/JOM.0b013e31825f2bea. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Rajaratnam S.M.W., Barger L.K., Lockley S.W., et al. Sleep disorders, health, and safety in police officers. JAMA. 2011;306(23):2567. doi: 10.1001/jama.2011.1851. [DOI] [PubMed] [Google Scholar]
- 20.Wu YK, Liu H. Associations Between Occupational Stress, Disordered Eating, and Obesity Among Police Officers in North Carolina. Obesities. 5(3):65. doi:10.3390/obesities5030065.
- 21.Can S.H., Hendy H.M. Behavioral variables associated with obesity in police officers. Ind Health. 2014;52(3):240–247. doi: 10.2486/indhealth.2013-0237. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Soteriades E.S., Smith D.L., Tsismenakis A.J., Baur D.M., Kales S.N. Cardiovascular disease in US firefighters: a systematic review. Cardiol Rev. 2011;19(4):202–215. doi: 10.1097/CRD.0b013e318215c105. [DOI] [PubMed] [Google Scholar]
- 23.Poston W.S.C., Haddock C.K., Jahnke S.A., Jitnarin N., Tuley B.C., Kales S.N. The prevalence of overweight, obesity, and substandard fitness in a population-based firefighter cohort. J Occup Environ Med. 2011;53(3):266–273. doi: 10.1097/JOM.0b013e31820af362. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Beckett A., Scott J.R., Chater A.M., Ferrandino L., Aldous JWF. The prevalence of metabolic syndrome and its components in firefighters: a systematic review and meta-analysis. Int J Environ Res Public Health. 2023;20(19):6814. doi: 10.3390/ijerph20196814. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Mathias K.C., Wu Y., Stewart D.F., Smith D.L. Differences in 5-year weight change between younger and older US firefighters. BMC Public Health. 2021;21(1):1215. doi: 10.1186/s12889-021-11266-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Rostami H., Tavakoli H.R., Rahimi M.H., Mohammadi M. Metabolic syndrome prevalence among armed forces personnel (Military Personnel and Police Officers): a systematic review and meta-analysis. Mil Med. 2019;184(9-10):e417–e425. doi: 10.1093/milmed/usz144. [DOI] [PubMed] [Google Scholar]
- 27.Mathias K.C., Bode E.D., Stewart D.F., Smith D.L. Changes in firefighter weight and cardiovascular disease risk factors over five years. Med Sci Sports Exerc. 2020;52(11):2476–2482. doi: 10.1249/MSS.0000000000002398. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Superko H.R., Momary K.M., Pendyala L.K., et al. Firefighters, heart disease, and aspects of insulin resistance: the FEMA firefighter heart disease prevention study. J Occup Environ Med. 2011;53(7):758–764. doi: 10.1097/JOM.0b013e31821f64c3. [DOI] [PubMed] [Google Scholar]
- 29.Folaron I., True M.W., Wardian J.L., et al. Effect of military deployment on diabetes mellitus in air force personnel. Mil Med. 2018;183(11-12):e603–e609. doi: 10.1093/milmed/usy050. [DOI] [PubMed] [Google Scholar]
- 30.Gibson R., Eriksen R., Singh D., et al. A cross-sectional investigation into the occupational and socio-demographic characteristics of British police force employees reporting a dietary pattern associated with cardiometabolic risk: findings from the Airwave Health Monitoring Study. Eur J Nutr. 2018;57(8):2913–2926. doi: 10.1007/s00394-017-1562-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Bescos R., Boden M.J., Jackson M.L., et al. Four days of simulated shift work reduces insulin sensitivity in humans. Acta Physiol. 2018;223(2) doi: 10.1111/apha.13039. [DOI] [PubMed] [Google Scholar]
- 32.Sondrup N., Termannsen A.D., Eriksen J.N., et al. Effects of sleep manipulation on markers of insulin sensitivity: a systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev. 2022;62 doi: 10.1016/j.smrv.2022.101594. [DOI] [PubMed] [Google Scholar]
- 33.Fekedulegn D., Burchfiel C.M., Charles L.E., Hartley T.A., Andrew M.E., Violanti J.M. Shift work and sleep quality among urban police officers: the BCOPS study. J Occup Environ Med. 2016;58(3):e66–e71. doi: 10.1097/JOM.0000000000000620. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Ulmer C.S., Bosworth H.B., Germain A., et al. Associations between sleep difficulties and risk factors for cardiovascular disease in veterans and active duty military personnel of the Iraq and Afghanistan conflicts. J Behav Med. 2015;38(3):544–555. doi: 10.1007/s10865-015-9627-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Barger L.K., Rajaratnam S.M.W., Wang W., et al. Common sleep disorders increase risk of motor vehicle crashes and adverse health outcomes in firefighters. J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med. 2015;11(3):233–240. doi: 10.5664/jcsm.4534. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Ma C.C., Gu J.K., Bhandari R., et al. Associations of objectively measured sleep characteristics and incident hypertension among police officers: The role of obesity. J Sleep Res. 2020;29(6) doi: 10.1111/jsr.12988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Romero Cabrera J.L., Sotos-Prieto M., García Ríos A., et al. Sleep and association with cardiovascular risk among midwestern US firefighters. Front Endocrinol. 2021;12 doi: 10.3389/fendo.2021.772848. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Kazman J.B., de la Motte S., Bramhall E.M.S., Purvis D.L., Deuster P.A. Physical fitness and injury reporting among active duty and National Guard/Reserve women: associations with risk and lifestyle factors. US Army Med Dep J. 2015:49–57. Published online. [PubMed] [Google Scholar]
- 39.Ramey S.L., Perkhounkova Y., Moon M., et al. Physical activity in police beyond self-report. J Occup Environ Med. 2014;56(3):338–343. doi: 10.1097/JOM.0000000000000108. [DOI] [PubMed] [Google Scholar]
- 40.Ras J., Kengne A.P., Smith D.L., Soteriades E.S., Leach L. Association between cardiovascular disease risk factors and cardiorespiratory fitness in firefighters: a systematic review and meta-analysis. Int J Environ Res Public Health. 2023;20(4):2816. doi: 10.3390/ijerph20042816. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Durand G., Tsismenakis A.J., Jahnke S.A., Baur D.M., Christophi C.A., Kales S.N. Firefighters’ physical activity: relation to fitness and cardiovascular disease risk. Med Sci Sports Exerc. 2011;43(9):1752–1759. doi: 10.1249/MSS.0b013e318215cf25. [DOI] [PubMed] [Google Scholar]
- 42.Barry A.M., Lyman K.L., Dicks N.D., McGeorge C.R., Carper M.J., Walch T.J. Firefighters are more physically active on-duty compared to off-duty. Int J Environ Res Public Health. 2020;17(24):9380. doi: 10.3390/ijerph17249380. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Elgaddal N., Kramarow E.A. Aerobic physical activity among adults age 18 and older: United States, 2024. NCHS Data Brief. 2026;(555) doi: 10.15620/cdc/174653. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Armed Forces Health Surveillance Center (AFHSC) Incidence and prevalence of select cardiovascular risk factors and conditions, active component, U.S. Armed Forces, 2003-2012. MSMR. 2013;20(12):16–19. [PubMed] [Google Scholar]
- 45.Lockie R.G., Orr R.M., Dawes J.J. Fit (and Healthy) for duty: blood lipid profiles and physical fitness test relationships from police officers in a health and wellness program. Int J Environ Res Public Health. 2022;19(9):5408. doi: 10.3390/ijerph19095408. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Glueck C.J., Kelley W., Wang P., Gartside P.S., Black D., Tracy T. Risk factors for coronary heart disease among firefighters in Cincinnati. Am J Ind Med. 1996;30(3):331–340. doi: 10.1002/ajim.4700300313. [DOI] [PubMed] [Google Scholar]
- 47.Sniderman A.D., Dufresne L., Pencina K.M., Bilgic S., Thanassoulis G., Pencina M.J. Discordance among apoB, non-high-density lipoprotein cholesterol, and triglycerides: implications for cardiovascular prevention. Eur Heart J. 2024;45(27):2410–2418. doi: 10.1093/eurheartj/ehae258. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Blumenthal R.S., Morris P.B., Gaudino M., et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of dyslipidemia: a report of the American College of Cardiology/American heart association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2026;87:2624–2757. doi: 10.1016/j.jacc.2025.11.016. Published online March 13,S0735-1097(25)10254-4. [DOI] [PubMed] [Google Scholar]
- 49.Mancuso J.D., Ahmed A.E., Rossi K.R. Tobacco and nicotine use among active component U.S. military service members: a comparison of 2018 estimates from the Health Related Behaviors Survey and the Periodic Health Assessment. MSMR. 2024;31(3):2–12. [PMC free article] [PubMed] [Google Scholar]
- 50.Haddock C.K., Jitnarin N., Poston W.S.C., Tuley B., Jahnke S.A. Tobacco use among firefighters in the central United States. Am J Ind Med. 2011;54(9):697–706. doi: 10.1002/ajim.20972. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Hartley T.A., Burchfiel C.M., Fekedulegn D., Andrew M.E., Violanti J.M. Health disparities in police officers: comparisons to the U.S. general population. Int J Emerg Ment Health. 2011;13(4):211–220. [PMC free article] [PubMed] [Google Scholar]
- 52.Phan L., McNeel T.S., Jewett B., Moose K., Choi K. Trends of cigarette smoking and smokeless tobacco use among US firefighters and law enforcement personnel, 1992-2019. Am J Ind Med. 2022;65(1):72–77. doi: 10.1002/ajim.23311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Yao Z., Tasdighi E., Dardari Z.A., et al. Association between cigarette smoking and subclinical markers of cardiovascular harm. J Am Coll Cardiol. 2025;85(10):1018–1034. doi: 10.1016/j.jacc.2024.12.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Vidyasagaran A.L., Siddiqi K., Kanaan M. Use of smokeless tobacco and risk of cardiovascular disease: a systematic review and meta-analysis. Eur J Prev Cardiol. 2016;23(18):1970–1981. doi: 10.1177/2047487316654026. [DOI] [PubMed] [Google Scholar]
- 55.Christodoulou A., Christophi C.A., Sotos-Prieto M., Moffatt S., Kales S.N. Eating habits among US firefighters and association with cardiometabolic outcomes. Nutrients. 2022;14(13):2762. doi: 10.3390/nu14132762. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Owens B.A., Whitney C.C., Hatch-McChesney A., et al. Higher baseline diet quality is positively associated with academic and physical performance among United States military academy cadets. Mil Med. 2026:usag032. doi: 10.1093/milmed/usag032. Published online February 12, [DOI] [PubMed] [Google Scholar]
- 57.Baggish A.L., Weiner R.B., Kanayama G., et al. Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction. Circ Heart Fail. 2010;3(4):472–476. doi: 10.1161/CIRCHEARTFAILURE.109.931063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.D’Andrea A., Caso P., Salerno G., et al. Left ventricular early myocardial dysfunction after chronic misuse of anabolic androgenic steroids: a doppler myocardial and strain imaging analysis. Br J Sports Med. 2007;41(3):149–155. doi: 10.1136/bjsm.2006.030171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Glazer G. Atherogenic effects of anabolic steroids on serum lipid levels. A literature review. Arch Intern Med. 1991;151(10):1925. [PubMed] [Google Scholar]
- 60.Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer D.S. Androgenic anabolic steroids and arterial structure and function in male bodybuilders. J Am Coll Cardiol. 2001;37(1):224–230. doi: 10.1016/s0735-1097(00)01083-4. [DOI] [PubMed] [Google Scholar]
- 61.Baggish A.L., Weiner R.B., Kanayama G., et al. Cardiovascular toxicity of illicit anabolic-androgenic steroid use. Circulation. 2017;135(21):1991–2002. doi: 10.1161/CIRCULATIONAHA.116.026945. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Vecchiato M., Ermolao A., Da Col M., et al. Mortality in male bodybuilding athletes. Eur Heart J. 2025;46(30):3006–3016. doi: 10.1093/eurheartj/ehaf285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.La Gerche A., Brosnan M.J. Cardiovascular effects of performance-enhancing drugs. Circulation. 2017;135(1):89–99. doi: 10.1161/CIRCULATIONAHA.116.022535. [DOI] [PubMed] [Google Scholar]
- 64.Emonson D.L., Vanderbeek R.D. The use of amphetamines in U.S. Air Force tactical operations during Desert Shield and Storm. Aviat Space Environ Med. 1995;66(3):260–263. [PubMed] [Google Scholar]
- 65.Smith D.L., DeBlois J.P., Kales S.N., Horn G.P. Cardiovascular strain of firefighting and the risk of sudden cardiac events. Exerc Sport Sci Rev. 2016;44(3):90–97. doi: 10.1249/JES.0000000000000081. [DOI] [PubMed] [Google Scholar]
- 66.Cohen H.W., Zeig-Owens R., Joe C., et al. Long-term cardiovascular disease risk among firefighters after the world trade center disaster. JAMA Netw Open. 2019;2(9) doi: 10.1001/jamanetworkopen.2019.9775. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Sloan N.L., Shapiro M.Z., Sabra A., et al. Cardiovascular disease in the world trade center health program general responder cohort. Am J Ind Med. 2021;64(2):97–107. doi: 10.1002/ajim.23207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Jordan H.T., Stellman S.D., Morabia A., et al. Cardiovascular disease hospitalizations in relation to exposure to the September 11, 2001 World Trade Center disaster and posttraumatic stress disorder. J Am Heart Assoc. 2013;2(5) doi: 10.1161/JAHA.113.000431. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Savitz D.A., Woskie S.R., Bello A., et al. Deployment to military bases with open burn pits and respiratory and cardiovascular disease. JAMA Netw Open. 2024;7(4) doi: 10.1001/jamanetworkopen.2024.7629. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Bello A., Savitz D.A., Rennix C., et al. The impact of burn pit waste segregation practices on respiratory and cardiovascular health risks among US military veterans deployed to Iraq and Afghanistan. Environ Health Glob Access Sci Source. 2025;24(1):40. doi: 10.1186/s12940-025-01195-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Murphy C.E., DeGroot D.W., O’Connor F.G. Exertional heat illness in active populations. Hardin CC, Guseh JS, Baggish A, eds. NEJM Evid. 2026;5(5) doi: 10.1056/EVIDra2500270. [DOI] [PubMed] [Google Scholar]
- 72.Wallace R.F., Kriebel D., Punnett L., Wegman D.H., Amoroso P.J. Prior heat illness hospitalization and risk of early death. Environ Res. 2007;104(2):290–295. doi: 10.1016/j.envres.2007.01.003. [DOI] [PubMed] [Google Scholar]
- 73.Huang Q., Ke L., Liu L., et al. Heatwave warnings mitigate long-term cardiovascular diseases risk from heat-related illness: a real-world prospective cohort study. Lancet Reg Health West Pac. 2025;55 doi: 10.1016/j.lanwpc.2025.101468. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Nzvere F.P., Tariq E., Nishanth K., Arshid A., Cancarevic I. Long-term cardiovascular diseases of heatstroke: a delayed pathophysiology outcome. Cureus. 2020;12(8):e9595. doi: 10.7759/cureus.9595. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Taylor A.J., Bindeman J., Feuerstein I., Cao F., Brazaitis M., O’Malley P.G. Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project. J Am Coll Cardiol. 2005;46(5):807–814. doi: 10.1016/j.jacc.2005.05.049. [DOI] [PubMed] [Google Scholar]
- 76.Santora L.J., Pillutla P., Norris T., et al. Coronary calcium scanning independently detects coronary artery disease in asymptomatic firefighters: a prospective study. J Cardiovasc Comput Tomogr. 2013;7(1):46–50. doi: 10.1016/j.jcct.2012.07.003. [DOI] [PubMed] [Google Scholar]
- 77.Ashen M.D., Carson K.A., Ratchford E.V. Coronary calcium scanning and cardiovascular risk assessment among firefighters. Am J Prev Med. 2022;62(1):18–25. doi: 10.1016/j.amepre.2021.06.005. [DOI] [PubMed] [Google Scholar]
- 78.Wanahita N., See J.L., Giedd K.N., Friedmann P., Somekh N.N., Bergmann S.R. No evidence of increased prevalence of premature coronary artery disease in New York City police officers as predicted by coronary artery calcium scoring. J Occup Environ Med. 2010;52(6):661–665. doi: 10.1097/JOM.0b013e3181e36457. [DOI] [PubMed] [Google Scholar]
- 79.Eckart R.E., Scoville S.L., Campbell C.L., et al. Sudden death in young adults: a 25-year review of autopsies in military recruits. Ann Intern Med. 2004;141(11):829–834. doi: 10.7326/0003-4819-141-11-200412070-00005. [DOI] [PubMed] [Google Scholar]
- 80.Eckart R.E., Shry E.A., Burke A.P., et al. Sudden death in young adults: an autopsy-based series of a population undergoing active surveillance. J Am Coll Cardiol. 2011;58(12):1254–1261. doi: 10.1016/j.jacc.2011.01.049. [DOI] [PubMed] [Google Scholar]
- 81.Smallman D.P., Webber B.J., Mazuchowski E.L., Scher A.I., Jones S.O., Cantrell J.A. Sudden cardiac death associated with physical exertion in the US military, 2005-2010. Br J Sports Med. 2016;50(2):118–123. doi: 10.1136/bjsports-2015-094900. [DOI] [PubMed] [Google Scholar]
- 82.Lear A., Patel N., Mullen C., et al. Incidence of sudden cardiac arrest and death in young athletes and military members: a systematic review and meta-analysis. J Athl Train. 2022;57(5):431–443. doi: 10.4085/1062-6050-0748.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Petek B.J., Churchill T.W., Moulson N., et al. Sudden cardiac death in national collegiate athletic association athletes: A 20-year study. Circulation. 2024;149(2):80–90. doi: 10.1161/CIRCULATIONAHA.123.065908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Phillips M., Robinowitz M., Higgins J.R., Boran K.J., Reed T., Virmani R. Sudden cardiac death in Air Force recruits. A 20-year review. JAMA. 1986;256(19):2696. [PubMed] [Google Scholar]
- 85.Shekhar A.C., Madhok M., Campbell T., Blumen I.J., Lyon R.M., Mann N.C. A comparison between sudden cardiac arrest on military bases and non-military settings. Am J Emerg Med. 2023;65:84–86. doi: 10.1016/j.ajem.2022.12.014. [DOI] [PubMed] [Google Scholar]
- 86.Smith D.L., Barr D.A., Kales S.N. Extreme sacrifice: sudden cardiac death in the US Fire Service. Extreme Physiol Med. 2013;2(1):6. doi: 10.1186/2046-7648-2-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Kales S.N., Soteriades E.S., Christoudias S.G., Christiani D.C. Firefighters and on-duty deaths from coronary heart disease: a case control study. Environ Health Glob Access Sci Source. 2003;2(1):14. doi: 10.1186/1476-069X-2-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Kales S.N., Soteriades E.S., Christophi C.A., Christiani D.C. Emergency duties and deaths from heart disease among firefighters in the United States. N Engl J Med. 2007;356(12):1207–1215. doi: 10.1056/NEJMoa060357. [DOI] [PubMed] [Google Scholar]
- 89.Farioli A., Yang J., Teehan D., Baur D.M., Smith D.L., Kales S.N. Duty-related risk of sudden cardiac death among young US firefighters. Occup Med. 2014;64(6):428–435. doi: 10.1093/occmed/kqu102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Farioli A., Christophi C.A., Quarta C.C., Kales S.N. Incidence of sudden cardiac death in a young active population. J Am Heart Assoc. 2015;4(6) doi: 10.1161/JAHA.115.001818. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Smith D.L., Haller J.M., Korre M., et al. The relation of emergency duties to cardiac death among US firefighters. Am J Cardiol. 2019;123(5):736–741. doi: 10.1016/j.amjcard.2018.11.049. [DOI] [PubMed] [Google Scholar]
- 92.Smith D.L., Haller J.M., Korre M., et al. Pathoanatomic findings associated with duty-related cardiac death in US firefighters: a case-control study. J Am Heart Assoc. 2018;7(18) doi: 10.1161/JAHA.118.009446. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Yang J., Teehan D., Farioli A., Baur D.M., Smith D., Kales S.N. Sudden cardiac death among firefighters ≤45 years of age in the United States. Am J Cardiol. 2013;112(12):1962–1967. doi: 10.1016/j.amjcard.2013.08.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Varvarigou V., Farioli A., Korre M., Sato S., Dahabreh I.J., Kales S.N. Law enforcement duties and sudden cardiac death among police officers in United States: case distribution study. BMJ. 2014;349:g6534. doi: 10.1136/bmj.g6534. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Violanti J.M., Fekedulegn D., Hartley T.A., Andrew M.E., Gu J.K., Burchfiel C.M. Life expectancy in police officers: a comparison with the U.S. general population. Int J Emerg Ment Health. 2013;15(4):217–228. [PMC free article] [PubMed] [Google Scholar]
- 96.Dow instruction 6130.03, volume 1 medical standards for military service: appointment, enlistment, or induction. 2026. https://www.esd.whs.mil/Portals/54/Documents/DD/issuances/dodi/613003_vol1.PDF?ver=8i9QED7mH4XAA4zoSSIwZA%3D%3D Published online February 3,
- 97.US Preventive Services Task Force. Davidson K.W., Barry M.J., et al. Screening for prediabetes and type 2 diabetes: US preventive services task force recommendation statement. JAMA. 2021;326(8):736. doi: 10.1001/jama.2021.12531. [DOI] [PubMed] [Google Scholar]
- 98.NFPA 1580 Standard for Emergency Responder Occupational Health and Wellness. 2025. https://www.nfpa.org/product/nfpa-1580-standard/p1580code Published online.
- 99.State of California Commission on Peace Officer Standards and Training Medical Examination and Evaluation Guidelines-Cardiovascular System. 2014. https://post.ca.gov/portals/0/post_docs/publications/medical-screening-manual/Cardio.pdf?bookmark#medical%20examination%20and%20evaluation%20guidelines Published online May.
- 100.Chou R., Arora B., Dana T., Fu R., Walker M., Humphrey L. Screening asymptomatic adults with resting or exercise electrocardiography: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;155(6):375–385. doi: 10.7326/0003-4819-155-6-201109200-00006. [DOI] [PubMed] [Google Scholar]
- 101.Sonaglioni A., Polymeropoulos A., Baravelli M., Nicolosi G.L., Lombardo M., Biondi-Zoccai G. Diagnostic accuracy of exercise stress testing, stress echocardiography, myocardial scintigraphy, and cardiac magnetic resonance for obstructive coronary artery disease: systematic reviews and meta-analyses of 104 studies published from 1990 to 2025. J Clin Med. 2025;14(17):6238. doi: 10.3390/jcm14176238. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Churchill T.W., Disanto M., Singh T.K., et al. Diagnostic yield of customized exercise provocation following routine testing. Am J Cardiol. 2019;123(12):2044–2050. doi: 10.1016/j.amjcard.2019.03.027. [DOI] [PubMed] [Google Scholar]
- 103.Bhatia H.S., Fan Y., Dharmavaram G., et al. Use of coronary artery calcium scoring in individuals with elevated lipoprotein(a): a multicohort study. J Am Coll Cardiol. 2026 doi: 10.1016/j.jacc.2026.02.5067. Published online March 16,S0735-1097(26)05437-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Epstein Y., Yanovich R. Heatstroke. N Engl J Med. 2019;380(25):2449–2459. doi: 10.1056/NEJMra1810762. [DOI] [PubMed] [Google Scholar]
- 105.Wilmore J.H., Joyner M.J., Freund B.J., Ewy G.A., Morton A.R. Beta-blockade and response to exercise: influence of training. Phys Sportsmed. 1985;13(7):60–69. doi: 10.1080/00913847.1985.11708832. [DOI] [PubMed] [Google Scholar]
- 106.Sinzinger H., O’Grady J. Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems. Br J Clin Pharmacol. 2004;57(4):525–528. doi: 10.1111/j.1365-2125.2003.02044.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Laufs U., Banach M., Mancini G.B.J., et al. Efficacy and safety of bempedoic acid in patients with hypercholesterolemia and statin intolerance. J Am Heart Assoc. 2019;8(7) doi: 10.1161/JAHA.118.011662. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Nissen S.E., Stroes E., Dent-Acosta R.E., et al. Efficacy and tolerability of evolocumab vs ezetimibe in patients with muscle-related statin intolerance: the GAUSS-3 randomized clinical trial. JAMA. 2016;315(15):1580. doi: 10.1001/jama.2016.3608. [DOI] [PubMed] [Google Scholar]
- 109.Virani S.S., Newby L.K., Arnold S.V., et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association/American college of cardiology joint committee on clinical practice guidelines. Circulation. 2023;148(9):e9–e119. doi: 10.1161/CIR.0000000000001168. [DOI] [PubMed] [Google Scholar]
- 110.Maron D.J., Hochman J.S., Reynolds H.R., et al. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med. 2020;382(15):1395–1407. doi: 10.1056/NEJMoa1915922. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Kim J.H., Baggish A.L., Levine B.D., et al. Clinical considerations for competitive sports participation for athletes with cardiovascular abnormalities: a scientific statement from the American heart association and american college of cardiology. J Am Coll Cardiol. 2025;85(10):1059–1108. doi: 10.1016/j.jacc.2024.12.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Pelliccia A., Sharma S., Gati S., et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J. 2021;42(1):17–96. doi: 10.1093/eurheartj/ehaa605. [DOI] [PubMed] [Google Scholar]
- 113.Kim J.H., Malhotra R., Chiampas G., et al. Cardiac arrest during long-distance running races. N Engl J Med. 2012;366(2):130–140. doi: 10.1056/NEJMoa1106468. [DOI] [PubMed] [Google Scholar]
- 114.Kim J.H., Rim A.J., Miller J.T., et al. Cardiac arrest during long-distance running races. JAMA. 2025;333(19):1699. doi: 10.1001/jama.2025.3026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Davenport E., Palileo E. United States Air Force Aerospace Medicine Waiver Guide Compendium. 2026. https://www.afrl.af.mil/Portals/90/Documents/711/USAFSAM/Air%20Force%20Waiver%20Guide%20Compendium.pdf Published online January 30.
- 116.van den Berk, Clark C., Chang J., Servey J., Quinlan J.D. Women’s health and the military. Prim Care. 2018;45(4):677–686. doi: 10.1016/j.pop.2018.07.006. [DOI] [PubMed] [Google Scholar]
- 117.Schamroth Pravda N., Karny-Rahkovich O., Shiyovich A., et al. Coronary artery disease in women: a comprehensive appraisal. J Clin Med. 2021;10(20):4664. doi: 10.3390/jcm10204664. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Castelletti S., Gati S. The female Athlete’s heart: overview and management of cardiovascular diseases. Eur Cardiol. 2021;16:e47. doi: 10.15420/ecr.2021.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.American diabetes association professional practice committee for diabetes*. 2. Diagnosis and classification of diabetes: standards of care in diabetes-2026. Diabetes Care. 2026;49(Supplement_1):S27–S49. doi: 10.2337/dc26-S002. [DOI] [PMC free article] [PubMed] [Google Scholar]



